Home/Filings/4/0001144204-12-020202
4//SEC Filing

Sackner-Bernstein Jonathan 4

Accession 0001144204-12-020202

CIK 0000320017other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 6:01 PM ET

Size

6.2 KB

Accession

0001144204-12-020202

Insider Transaction Report

Form 4
Period: 2012-04-02
Sackner-Bernstein Jonathan
VP Clinical Dev & Reg Affairs
Transactions
  • Award

    Stock Option (right to purchase)

    2012-04-02+400,000400,000 total
    Exercise: $0.38Exp: 2022-04-01Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]On April 2, 2012, the commencement date (the "Commencement Date") of his employment with NeoStem, Inc. (the "Company"), the Reporting Person was granted an option to purchase 400,000 shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), pursuant and subject to the terms and conditions of the Company's 2009 Equity Compensation Plan. This option shall vest as to 100,000 shares on each of December 31, 2012, April 2, 2013, April 2, 2014, and April 2, 2015, provided that the Reporting Person remains employed by the Company on each of such dates.

Issuer

NeoStem, Inc.

CIK 0000320017

Entity typeother

Related Parties

1
  • filerCIK 0001546561

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 6:01 PM ET
Size
6.2 KB